Organisation paid for research Program year 2024 Source: CMS Open Payments

Bio Kinetic Clinical

Neither a doctor nor a teaching hospital

Research payments

$1,226,680

56 payments

Through program year 2024, Bio Kinetic Clinical is reported as receiving $1,226,680 in research payments, across 56 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2024	Research	$6,883	1
2023	Research	$207,992	18
2022	Research	$226,288	27
2021	Research	$785,516	10

Breakdown

Who paid Research payments · program years 2021–2024

Noven Pharmaceuticals, Inc. $785,516 10 payments
GlaxoSmithKline, LLC. $441,164 46 payments

Studies the money was for Research payments · program years 2021–2024

A Phase I Study to Assess Skin Irritation and Sensitization of Hp-1050 Transdermal System Compared to Xulane in Healthy Adult Females $785,516 10 payments
A Phase 1/2, First-Time-In Human (Ftih), Randomized, Observer-Blind, P $396,981 30 payments
A Phase 3, Randomized, Placebo-Controlled, Observer-Blind, Multi-Count $20,339 4 payments
A Phase I/II, Randomised, Controlled Study to Assess the Safety, Effec $17,087 11 payments
Phase Iiib, Observer-Blind, Randomized, Placebo-Controlled, Multi-Cent $6,757 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.